Communications Medicine, 2025
Plasma-based brain age as a potential biomarker for cognitive health and risk of brain-related disorders

Wang B., Ding H., Qi D. et al.

Carbohydrate Polymers, 2025
A novel fructan from Atractylodes macrocephala ameliorates ulcerative colitis through gut microbiota-mediated PI3K/Akt signaling

Wu J., Xu Q., Yang Y. et al.

Annals of Clinical and Translational Neurology, 2025
Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐ AChR Antibody‐Positive Myasthenia Gravis: FGF ‐19 as a Novel Biomarker

Luo T., Peng D., Zhang Z. et al.

Rheumatology Advances in Practice, 2025
Disentangling patient, disease, and treatment effects: proteomic and metabolomic differences in early versus established psoriatic arthritis

Bentvelzen M., el Bouhaddani S., Spierings J. et al.

Nature Genetics, 2025
A genome-wide association study of mass spectrometry proteomics using a nanoparticle enrichment platform

Suhre K., Chen Q., Halama A. et al.

Gut Microbes, 2025
Antibiotic cocktail-induced changes in gut microbiota drive alteration of bile acid metabolism to restrain Th17 differentiation through the FXR–NLRP3 axis

Shao-Yu Y., Niu D., Chen J. et al.

Cell Reports Medicine, 2025
L-Phenylalanine is a metabolic checkpoint of human Th2 cells

Kulkarni A., Rodriguez-Coira J., Stocker N. et al.

Scientific Reports, 2025
Inflammatory response in bacteremia survivors and non-survivors: a case-control study

Ojanen M., Seiskari T., Aittoniemi J. et al.

Nature Aging, 2025
Organ-specific proteomic aging clocks predict disease and longevity across diverse populations

Wang Y., Xiao S., Liu B. et al.

Nature Communications, 2025
Personal, social, and natural co-exposure pattern and plasma proteins in cardiometabolic diseases

Tang X., Xu H., Wu G. et al.

BMC Oral Health, 2025
Methodological comparison between salivary and plasma inflammatory biomarkers in third molar surgery patients

Eriksson L., Larsson A., Eriksson M. et al.

British Journal of Pharmacology, 2025
UK Biobank: Transforming drug discovery and precision medicine

Bešević J., Said S., Nagy R. et al.

Molecular Neurobiology, 2025
Mendelian Randomization Unlocks Stroke Therapeutics: Dioscin Inhibits CD27-Driven Neuroinflammation via Gut Microbiota Modulation

Tan H., Li S., Yan H. et al.

Clinical Cancer Research, 2025
Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors

Perez K., Horick N., Baginksa J. et al.

Journal of Pediatric Gastroenterology and Nutrition, 2025
A set of serum proteomic biomarkers differentiates celiac children from age and human leukocyte antigen‐matched healthy controls

Mandile R., di Tolla M., Carpinelli M. et al.

Coronary Artery Disease, 2025
Matrix metalloproteinase-1 and interleukin-17A are associated with previous plaque disruption: a combined proteomics and optical coherence tomography study

Covani M., Niccoli G., Niida T. et al.

JCI Insight, 2025
FMT promotes type 2 mucosal immune responses with colonic epithelium proliferation in recurrent CDI patients

Moreau G., Tian J., Natale N. et al.

Journal of Crohn's and Colitis, 2025
Serum Protein Profiles Differ with Adalimumab and Ustekinumab Treatment in Moderately to Severely Active Crohn’s Disease

Venkat S., Zeeman M., Hart A. et al.

Nature Communications, 2025
Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia

Prummel K., Woods K., Kholmatov M. et al.

Human Molecular Genetics, 2025
Observational and Mendelian randomization studies of plasma sclerostin levels do not provide evidence of cardiovascular adverse effects of sclerostin inhibition

Thorolfsdottir R., Sveinbjornsson G., Hjorleifsson Eldjarn G. et al.